⌘K

Home/Filings/4/0000810084-09-000013

4//SEC Filing

CHASE RANDAL D 4

Accession 0000810084-09-000013

CIK 0000810084other

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 8:01 PM ET

Size

7.4 KB

Accession

0000810084-09-000013

Insider Transaction Report

Form 4

Period: 2009-06-05

BIOJECT MEDICAL TECHNOLOGIES INCBJCT

Director

Transactions

Exercise/Conversion
Restricted Stock Unit
2009-06-05−19,000→ 0 total
From: 2009-06-05→ BJCT Common Stock (19,000 underlying)
Exercise/Conversion
BJCT Common Stock
2009-06-05+19,000→ 92,500 total

Footnotes (3)

[F1]50% vesting per June 5, 2008 Board Grant.
[F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
[F3]No expiration date.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOJECT MEDICAL TECHNOLOGIES INC

CIK 0000810084

Entity typeother

Related Parties

1

filerCIK 0001078784

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 8:01 PM ET
Size: 7.4 KB

View on SEC.gov